News

An age-stratified analysis of endothelial cell count in diabetic and non-diabetic corneas found no statistically significant difference between the groups. Since diabetes may damage the inner layer of the cornea, other variables that affect cell health must also be evaluated.

Forward-looking research in drug delivery and therapies filled the sessions at this year’s meeting of the Association for Research in Vision and Ophthalmology.

Targeting of Myo/Nog cells using a novel nanocarrier complex loaded with doxorubicin is showing promise as a treatment for reducing posterior capsule opacification.

While practice may not always make perfect (at least in this life), it definitely does “make better” not only in sports, but also in the operating room.

Combination treatment with squalamine lactate ophthalmic solution 0.2% and ranibizumab PRN resulted in improved visual function in patients with neovascular age-related macular degeneration compared with treatment with ranibizumab alone.

A novel anti-vascular endothelial growth factor agent, RTH258, produced rapid and sustained improvements in visual acuity and central subfield thickness and was non-inferior to aflibercept in a phase II trial.

New surveillance data on antibiotic resistance among ocular pathogens shows worrisome trends for some widely used drugs while resistance rates for some isolates were relatively stable.

Serial measurements of sirolimus blood concentrations after intravitreal injection show the maximum concentration achieved was below the level generally associated with systemic immunosuppression.

John Berdahl, MD, is the developer of Balance Goggles, eyewear intended to help regulate the pressure inside the eye.

The addition of phenylephrine 1%/ketorolac 0.3% injection to the irrigation bottle maintains pupil dilation and makes patients more comfortable intra- and postoperatively.

Degeneration of rods in eyes with RP leads to night vision problems and loss of rod-derived cone viability factor (RdCVF) that is necessary for cone survival. Replacing RdCVF may prevent cone degeneration and loss of central vision.

A whole-hearted commitment to building and designing a dispensary from the ground up is vital for its success, explain those who have first-hand experience.

In her debut blog, Georgette Pascale shares her must-have PR tips that every doctor must know to ensure a successful practice.

Find out how to improve your surgical work flow, reducing the total phaco time and total amount of fluid in cataract procedures while you stay very safe and efficient.

Does your state make the list?

Tell Ophthalmology Times what areas you wish we covered more by taking this short survey.

Retinal microglia contribute to rod demise in retinitis pigmentosa-a blinding hereditary retinal disease for which there is currently no approved treatment, according to a recent study.

Gene therapy to treat choroideremia is one step closer to reality thanks to a new study.

Topical glaucoma drops have potential for causing profound structural soft-tissue changes.

Dr. McDonald advises taking a second visit to an established dry eye center of excellence a few months after your first visit. Begin by implementing the osmolarity units, train staff, and promote that your office is now a center of dry eye excellence. Watch more on how to be successful!”

While many people across the United States are hosting barbeques, attending parades and firework displays, and picnicking with their families today, ophthalmologists may find themselves celebrating Independence Day a little differently-handling emergencies due to firework-related eye injuries.

In our continued series, Uday Devgan, MD, FACS, shares what he wishes he knew in med school.

The first case series report of femtosecond laser flap creation for LASIK in eyes that have undergone radial keratotomy showed the technique was successful when novel settings were used. No significant intraoperative or postoperative complications were reported in the 27 eyes in the study, and uncorrected visual acuity improved significantly.

Patients with symptomatic vitreomacular adhesion (VMA) find that a single intravitreal injection of ocriplasmin improves their vision, according to an ancillary analysis of two multicentre randomised clinical trials reported in JAMA Opthalmology.

Google Glass may be the answer for retina surgeons who struggle to record scleral buckling surgery, according to a recent study published in JAMA Ophthalmology.

In the first of a four-part series, Arun C. Gulani, MD, discusses the concept and approach to designing primary cataract surgery.

One thing that is interesting about the Medicare data is how much goes to the top 1% of physician billers.

Managers can teach staff many skills but often the most difficult lesson for employees to learn is they need to be aware of the chaos they consciously or unconsciously create.

Real-world experience with ocriplasmin indicates it is an effective, safe, and cost-effective treatment for symptomatic vitreomacular adhesion in properly selected eyes.

The Raindrop Near Vision Inlay (Revision Optics) improves near-visual performance without added visual disturbance in pseudophakic patients.